Ajay Kumar Dhadha

Ajay Kumar Dhadha is recorded as Board Member and Chairman at Raphael Pharmaceutical Inc. (RAPH) since January 8, 2025. Raphael Pharmaceutical Inc. reported in an 8-K filed July 17, 2026 that Ajay Kumar Dhadha resigned as Director, effective June 30, 2026. Raphael Pharmaceutical Inc. reported in an 8-K filed July 17, 2026 that Ajay Kumar Dhadha resigned as Chairman of the Board of Directors, effective June 30, 2026. Raphael Pharmaceutical Inc. reported in an 8-K filed January 14, 2025 that Ajay Kumar Dhadha was appointed Chairman of the Board, effective January 8, 2025. Equibles holds 4 filed executive changes naming Ajay Kumar Dhadha; each is listed under recent activity with its source filing. Raphael Pharmaceutical Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Raphael Pharmaceutical Inc. includes Uri Tadelis (CFO), DR.IGAL LOURIA HAYON (CTO), Dr. Igal Louria Hayon (Board Member) and 1 other.